Showing 1,921 - 1,940 results of 8,137 for search 'significantly ((((greater decrease) OR (observed decrease))) OR (mean decrease))', query time: 0.43s Refine Results
  1. 1921

    Postoperative drainage(ml) (M(IQR)). by Na Wang (193263)

    Published 2024
    “…</p><p>Results</p><p>We found that numerical rating scale(NRS) score and incidence of breast fistula in group A were significantly lower than other, the continuous decrease of postoperative drainage in group A was higher than other, there were significant differences among groups (p<0.001). …”
  2. 1922
  3. 1923
  4. 1924
  5. 1925
  6. 1926
  7. 1927
  8. 1928

    DPOAE differences (in dB SPL), delayed observation minus baseline, as a function of the F2 frequency. by Eddy Fortier (20577301)

    Published 2025
    “…For each participant, graphs on the top row are for the left ear, while graphs on the bottom row are for the right ear. Significant amplitude decreases [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0309513#pone.0309513.ref049" target="_blank">49</a>] are highlighted with a red background. …”
  9. 1929
  10. 1930

    Advantages of Novel Anti-cancer Selenosemicarbazones: Preferential Reactivity of Their Fe(III), Cu(II), and Zn(II) Complexes with Key Physiological Reductants/Ligands Versus Isoste... by Mahendiran Dharmasivam (14165426)

    Published 2025
    “…The role of glutathione in all three latter reactions is significant, given the greater reactivity of the selenosemicarbazone, and glutathione’s key role in selenosemicarbazone and thiosemicarbazone anticancer activity.…”
  11. 1931

    Advantages of Novel Anti-cancer Selenosemicarbazones: Preferential Reactivity of Their Fe(III), Cu(II), and Zn(II) Complexes with Key Physiological Reductants/Ligands Versus Isoste... by Mahendiran Dharmasivam (14165426)

    Published 2025
    “…The role of glutathione in all three latter reactions is significant, given the greater reactivity of the selenosemicarbazone, and glutathione’s key role in selenosemicarbazone and thiosemicarbazone anticancer activity.…”
  12. 1932
  13. 1933
  14. 1934
  15. 1935
  16. 1936
  17. 1937
  18. 1938
  19. 1939
  20. 1940